For the year ending 2025-12-31, BRTX has $4,079,635 in assets. $1,511,188 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,511,188 | |||
| Investments held in marketable securities | 1,441,734 | |||
| Accounts receivable | 15,500 | |||
| Prepaid expenses and other current assets | 168,440 | |||
| Total current assets | 3,136,862 | |||
| Deferred offering costs | 49,808 | |||
| Property plant and equipment gross | 1,590,141 | |||
| Less accumulated depreciation | 1,231,374 | |||
| Property and equipment, net | 358,767 | |||
| Intangible assets, net | 534,198 | |||
| Total assets | 4,079,635 | |||
| Accounts payable | 1,341,495 | |||
| Accrued expenses and other current liabilities | 982,047 | |||
| Warrant liabilities | 1,399,349 | |||
| Total current liabilities | 3,722,891 | |||
| Statementclassofstockaxis | 13,982 | |||
| Common stock, 0.0001 par value 75,000,000 shares authorized 8,876,242 and 6,919,919 shares issued and outstanding at december 31, 2025 and 2024, respectively | 887 | |||
| Additional paid-in capital | 170,262,565 | |||
| Accumulated deficit | -169,920,690 | |||
| Total stockholders equity | 356,744 | |||
| Total liabilities and stockholders equity | 4,079,635 | |||
BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies, Inc. (BRTX)